The science behind the shift toward subcrestal implants
by Dr. LeRoy Horton
You cannot have been an implant
provider in the past 10 years
and not have had a conversation
with a colleague about the
nuances of epicrestal versus subcrestal
implant placement. Dentists are
great at following protocols; however,
many practitioners face great difficulty in articulating a sound argument
for why they perform a protocol
or when it is appropriate. This short
article will attempt to provide some
language regarding implant depth in light of current concepts.
I should probably begin by explaining
that when I refer to implant depth,
I’m referring to the placement of the
roughened surface of a dental implant
that is meant to be osseointegrated.
For most cases, this conversation will
revolve around bone-level implants;
tissue-level implants are designed with
a polished transmucosal collar that
provides no osseointegrative properties.
Bone-level implants, despite
some variations in collar designs, are typically meant to have bone contact
all the way up the shoulder.
When we consider the classic
definition of implant success, peri- and
postintegration bone levels
have always been important factors.
Albrektsson described this as less
than 0.2 mm of vertical bone loss
annually after the first year of service.1
Understanding this can be daunting.
Our responsibility shifts from placing
implants in bone to now keeping
that bone from resorbing over time. There are many surgical and restorative
aspects that have to be properly
accommodated to achieve this.
As mentioned in the introduction,
implant depth will be the focus.
If you have placed enough
implants, you will have experienced
the phenomenon of marginal bone
remodeling. In some patients, this is
very noticeable, while in others it is
indiscernable.
Material-level innovations such as
platform switch connections have
proven to minimize initial bone loss.2
Biologically, however, there is overwhelming
evidence that the thickness
of the peri-implant soft tissues plays a
major role as well. As part of a series
of studies, Linkevicius showed that
tissue thickness, or lack thereof, was
correlated to statistically significant
differences in marginal bone loss
when bone-level implants were placed
at the level of the crest. One of these
studies involving the placement of 80
crestal level implants showed that 85%
of the implants placed in thick tissue
(> 2mm) showed either no bone loss or
nor more than 0.5 mm after one year,
where 70% of implants in thin tissue
(< 2mm) showed 1 mm of loss or more.3
Traditionally, dentists trained in
soft-tissue surgery have addressed
thin tissue with augmenting procedures
involving autologous connective
tissue grafts, gingival grafts, allografts
and xenograft products. These wide
array of surgeries, which have collectively
been termed “periodontal
plastic surgery,” have since the 1980s
proven very predictable in augmenting
patients’ mucogingival complexes.4
Another study by Linkevicius of 102
implants showed that thickening thin
tissue (< 2mm) with allogenic membrane
compared with no added membrane
reduced crestal bone loss after
one year from 1.81 mm to 0.44 mm.5
Given that the supracrestal attachment
apparatus (formerly known as
the biologic width) around implants
resemble that of natural teeth, albeit
a bit greater in dimensions, thicker
tissues translate to greater protection
against the oral environment. With a
junctional epithelium of 1.4–2.9 mm,
and connective that is usually 0.7 to
2.6 mm, full dimensions including the
sulcus can range from 3.5 to 6 mm.6
Establishing that a thick or thickened
peri-implant gingival complex
is beneficial leads us to the question
of whether placing an implant deeper
in the crest is a viable way to create
a thicker complex of vertical tissue
without grafting. In other words, if
there is only 1.5 mm of tissue width
over the crest, can I place an implant
1 mm subcrestal (as long as I’m not
violating any vital anatomical structures)
and have a result of 2.5 mm of
vertical distance to the oral environment?
The answer is a resounding yes!
(See Figs. 1a–1c.) The data appears to
support this phenomenon.7
Fig. 1a: Illustration of site with adequate thick
soft tissue of > 2 mm and an implant placed
epicrestal.
Fig. 1b: Illustration of site with thin soft tissue
< 2 mm and the implant placed subcrestal.
Fig. 1c: Illustration of site with subcrestal implant
placed in thin tissue after healing and showing a
now-thick tissue over the implant.
The follow-up to that question is
whether this form of what we can call
a passive tissue augmentation bears
the same benefits as the aforementioned
methods. So far, the literature appears to cautiously support this.
Valles et al., in a systemic review and
meta-analysis, found that implants
placed in a subcrestal position have
less marginal bone loss changes
when compared with implants placed
epicrestal,8 while Cruz et al., also in a
systematic review and meta-analysis,
found no statistical significance.9 An
entire textbook has been written on
this protocol,10 as well as many studies
that at best afirm the benefits or at
worst demonstrate no harm. Hence,
there appears to be a very compelling
argument … as long as one can understand
and articulate it.
Obviously, the location of implant
placement considers many factors,
including position of the CEJ on
neighboring teeth, bone dimensions,
restoration angle and size, and aesthetic
demands. Also, we can’t forget
the caveat of not needing to place an
implant deeper if the soft tissue is
already thick. Figs. 2a and 2b illustrate
one of my cases demonstrating this
concept: The soft-tissue outline can be
seen above the bone mesial and distal
to the implant, and we can appreciate
the new vertical soft-tissue dimension
over the implant by placing it about
1 mm subcrestal.
Fig. 2a: Radiograph showing a two-year follow-up of an
implant placed subcrestal, with the red arrow indicating
the tissue thickness over the bone and the yellow arrow
indicating the tissue thickness over the implant.
Fig. 2b: Intraoral photograph of the same implant.
With every shift in paradigm, an
older generation of clinicians will
require convincing articulation of
the change to, if not accept it, at
least respect it. Subcrestal implant
placement appears to be one of these
current paradigms in our industry.
References
1. Albrektsson T, Zarb G, Worthington P, Eriksson A. The longterm
efficacy of currently used dental implants: a review
and proposed criteria of success. Int J Oral Maxillofac
Implants 1986; 1(1):11–25.
2. Calvo-Guirado JL, Cambra J, Tarnow DP. The effect of
interimplant distance on the height of the interimplant
bone crest when using platform-switched implants. Int J
Periodontics Restorative Dent 2009; 29:141–51.
3. Linkevicius T, Puisys A, Steigmann M, Vindasiute E,
Linkeviciene L. Influence of vertical soft tissue thickness
on crestal bone changes around implants with platform
switching: a comparative clinical study. Clin Implant Dent
Relat Res 2015; 17(6):1228–36.
4. Langer B, Calagna L. The subepithelial connective tissue
graft. J Prosthetic Dent 1980; 44(4):363–67.
5. Linkevicius T, Puisys A, Linkeviciene L, Peciuliene V, Schlee
M. Crestal bone stability around implants with horizontally
matching connection after soft tissue thickening: a
prospective clinical trial. Clin Implant Dent Relat Res 2015;
17(3):497–508.
6. Linkevicius T, Apse P. Biologic width around implants. An
evidence-based review. Stomatologija 2008; 10(1):27–35.
7. Linkevicius T, Puisys A, Linkevicius R, et al. The influence
of submerged healing abutment or subcrestal implant
placement on soft tissue thickness and crestal bone
stability. A 2 year randomized clinical trial. Clin Implant
Dent Relat Res 2020; 22(4):497–506.
8. Valles C, Rodríguez-Ciurana X, Clementini M, et al.
Influence of subcrestal implant placement compared with
equicrestal position on the peri-implant hard and soft
tissues around platform-switched implants: a systematic
review and meta-analysis. Clin Oral Investig 2018;
22:555–70.
9. Cruz RS, Lemos CAA, de Luna Gomes JM, et al. Clinical
comparison between crestal and subcrestal dental
implants: A systematic review and meta-analysis. J
Prosthetic Dent 2022; 127(3):408–17.
10. Linkevicius T. Zero Bone Loss Concepts. Quintessence
Publishing Berlin, Germany; 2019.
Dr. LeRoy Horton, MS, DICOI, a periodontist in the greater Seattle
area, is a longtime contributor to Dentaltown magazine and serves on
its editorial advisory board. Horton earned his DDS from the University
of Washington and a master’s in periodontal science from Oregon
Health Sciences University. He is an associate professor and director
of the periodontics and implant curriculum at Pacific Northwest Health
Sciences University School of Dental Medicine and practices part time.